<p>(A) Weight gain in mice during PNU-282987 treatment. At the end of PNU-282987 treatment, (B) HOMA-IR, (C) insulin tolerance test (ITT) and (D, E) glucose tolerance test (GTT) were performed. ITT was performed in mice 6 h after food removal with insulin challenge at 0.55 IU/kg of body weight (i.p.). GTT was performed in overnight fasted mice with glucose challenge at 2.0 g/kg of body weight (i.p.). Data are means ± SE (n = 5–6). <sup>*</sup><i>P</i><0.05, <sup>**</sup><i>P</i><0.01 <i>vs</i> saline treatment.</p
CNTO736 is a glucagon-like peptide (GLP) 1 receptor agonist that incorporates a GLP-1 peptide analog...
<p>A, Insulin tolerance tests (ITT) were performed in age-matched control and knockout mice (n = 8–2...
<p>A) Fasted glucose of WT (n = 6) and T1R3 KO (n = 9) mice. B) IP GTT in WT (n = 6) and T1R3 KO (n ...
<p>(A) Genotype characterization by PCR analysis of tail DNA from offspring derived from heterozygou...
<p>Western blots in (A) skeletal muscle, (B) visceral adipose and (C) liver in wild type mice after ...
ims/hypothesisTreatment with theα3β4 nicotinic acetylcholine receptor (nAChR) agonist, 1,1-dimethyl-...
<p>An OGTT (3 g/kg) was performed after drug administration for 14 days. (a) Blood glucose in TAC tr...
Aims/hypothesis Treatment with the alpha 3 beta 4 nicotinic acetylcholine receptor (nAChR) agonist, ...
<p><b>A)</b> Glucose tolerance tests were performed by injecting 1 mg/kg body weight of glucose ip a...
<p>Seven-week-old male <i>db/db</i> mice subcutaneously received either the EP4-selective agonist ON...
<p>Male db/db mice were treated with vehicle (0.9% NaCl; n = 8) or with NRG1 (50 μg.kg<sup>-1</sup>;...
<p>For assessing insulin sensitivity, fasting blood glucose (A), fasting serum insulin level (B) and...
<p>(A, D) No significant change was observed on blood glucose levels during the OGTT between vehicle...
<p>(A) Intraperitoneal glucose tolerance test (ipGTT) in males after 16 wk of HFD. (B) Respective ar...
<p>A–F, Body weight (A, <i>n</i> = 14–16 mice per group), glucose levels and glucose level area unde...
CNTO736 is a glucagon-like peptide (GLP) 1 receptor agonist that incorporates a GLP-1 peptide analog...
<p>A, Insulin tolerance tests (ITT) were performed in age-matched control and knockout mice (n = 8–2...
<p>A) Fasted glucose of WT (n = 6) and T1R3 KO (n = 9) mice. B) IP GTT in WT (n = 6) and T1R3 KO (n ...
<p>(A) Genotype characterization by PCR analysis of tail DNA from offspring derived from heterozygou...
<p>Western blots in (A) skeletal muscle, (B) visceral adipose and (C) liver in wild type mice after ...
ims/hypothesisTreatment with theα3β4 nicotinic acetylcholine receptor (nAChR) agonist, 1,1-dimethyl-...
<p>An OGTT (3 g/kg) was performed after drug administration for 14 days. (a) Blood glucose in TAC tr...
Aims/hypothesis Treatment with the alpha 3 beta 4 nicotinic acetylcholine receptor (nAChR) agonist, ...
<p><b>A)</b> Glucose tolerance tests were performed by injecting 1 mg/kg body weight of glucose ip a...
<p>Seven-week-old male <i>db/db</i> mice subcutaneously received either the EP4-selective agonist ON...
<p>Male db/db mice were treated with vehicle (0.9% NaCl; n = 8) or with NRG1 (50 μg.kg<sup>-1</sup>;...
<p>For assessing insulin sensitivity, fasting blood glucose (A), fasting serum insulin level (B) and...
<p>(A, D) No significant change was observed on blood glucose levels during the OGTT between vehicle...
<p>(A) Intraperitoneal glucose tolerance test (ipGTT) in males after 16 wk of HFD. (B) Respective ar...
<p>A–F, Body weight (A, <i>n</i> = 14–16 mice per group), glucose levels and glucose level area unde...
CNTO736 is a glucagon-like peptide (GLP) 1 receptor agonist that incorporates a GLP-1 peptide analog...
<p>A, Insulin tolerance tests (ITT) were performed in age-matched control and knockout mice (n = 8–2...
<p>A) Fasted glucose of WT (n = 6) and T1R3 KO (n = 9) mice. B) IP GTT in WT (n = 6) and T1R3 KO (n ...